ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,583, issued on Nov. 11, was assigned to Navitor Pharmaceuticals Inc. (Boston).
"Methods of treatment using an mTORC1 modulator" was invented by Steven Leventer (Boston) and Steven D. Targum (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods, compositions, and unit dosage forms useful for selectively modulating mTORC1 activity."
The patent was filed on June 29, 2023, under Application No. 18/216,307.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&...